ReviewCurrent cardiology reports2025
Left Atrial Coupling Index for the Prediction of Atrial Fibrillation and Heart Failure: Current Evidence and Clinical Implications.
Review in Current cardiology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- AI-enabled left atrial volume quantification from CAC CT: comparison with echocardiography.The international journal of cardiovascular imaging · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewThe aim of this review paper is to explore the clinical utility of left atrial coupling indices—LACI-v/m (volumetric/mechanical) and LACI-av (atrioventricular volumetric)—as emerging predictors of atrial fibrillation (AF) and heart failure (HF). It emphasizes their relevance in the context of diastolic dysfunction and left heart remodeling. RECENT
findingsLACI-v/m, calculated by dividing indexed left atrial volume by a′ velocity, has been independently associated with incident AF and HF across diverse populations. LACI-av, defined as the ratio of left atrium (LA) to left ventricular (LV) end-diastolic volumes, is applicable in AF and has demonstrated predictive value for AF, HF, and mortality using echocardiography, cardiac MRI, and CT. A meta-analysis confirmed a significant association between elevated LACI and AF risk. Given the interdependence of LA and LV function, both LACI-v/m and LACI-av enhance cardiovascular risk stratification by integrating left atrial structure and function. Future prospective studies are needed to validate standardized thresholds and guide LACI-based management strategies.
Indexed as
Identifiers
41129030What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.